Predictors of Long-term Therapy with Glucocorticoid in Polymyalgia Rheumatica

被引：0
|
作者：
Aoki, Akiko [1 ]
Kobayashi, Hiroshi [1 ]
Oka, Hiroshi [1 ]
机构：
[1] Tokyo Med Univ, Hachioji Med Ctr, Hachioji, Tokyo, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0766
引用
收藏
页数：2
相关论文
共 50 条
  • [21] LONG-TERM GLUCOCORTICOID MONOTHERAPY CAN LEAD TO REMISSION IN JAPANESE PATIENTS WITH POLYMYALGIA RHEUMATICA WITHOUT NOTABLE ADVERSE EFFECTS
    Aoki, A.
    Senuma, A.
    Osada, A.
    Nagaoka, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1085 - 1086
  • [22] Predictors of glucocorticoid-free remission in patients with polymyalgia rheumatica treated with prednisolone
    Hattori, Kyosuke
    Hirano, Yuji
    Kojima, Toshihisa
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (11) : 1581 - 1586
  • [23] Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy
    Shunsuke Mori
    Yukinori Koga
    Clinical Rheumatology, 2016, 35 : 1367 - 1375
  • [24] Bone Protection in Patients with Polymyalgia Rheumatica (PMR) Receiving Glucocorticoid Therapy
    Miley, C.
    O Mara, G.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S244 - S245
  • [25] Long-term glucocorticoid treatment in patients with polymyalgia rheumatica: can we just move a step forward? Comments on "Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis"
    Manzo, Ciro
    CLINICAL RHEUMATOLOGY, 2021, 40 (10) : 4367 - 4368
  • [26] Withdrawal of Glucocorticoid Therapy is Difficult in Women with Polymyalgia Rheumatica: An Observational Study
    Aoki, Dai
    Kajiwara, Nobuyuki
    Irishio, Keiko
    Kato, Yasuhiro
    Suezaki, Shinya
    Kageyama, Misaki
    Misago, Masahiro
    Tamai, Daisuke
    Nakao, Shinichiro
    Ueoka, Takato
    Ito, Mototoshi
    Murakami, Shinichiro
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 6417 - 6422
  • [27] Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy
    Mori, Shunsuke
    Koga, Yukinori
    CLINICAL RHEUMATOLOGY, 2016, 35 (05) : 1367 - 1375
  • [28] PREDICTING DURATION OF GLUCOCORTICOID THERAPY IN AN INCEPTION COHORT OF PATIENTS WITH POLYMYALGIA RHEUMATICA
    Morton, Chris
    Muller, Sara
    Hider, Samantha
    Belcher, John
    Mallen, Christian D.
    Helliwell, Toby
    RHEUMATOLOGY, 2019, 58 : 176 - 176
  • [29] Long-term glucocorticoid treatment in patients with polymyalgia rheumatica: can we just move a step forward? Comments on “Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis”
    Ciro Manzo
    Clinical Rheumatology, 2021, 40 : 4367 - 4368
  • [30] GLUCOCORTICOID-RESISTANT POLYMYALGIA RHEUMATICA: CLINICAL CHARACTERIZATION AND TOCILIZUMAB THERAPY
    Mori, S.
    Koga, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1002 - 1003
12345